Patent 10899761 was granted and assigned to Plexxikon Inc. on January, 2021 by the United States Patent and Trademark Office.
Provided herein are heterocyclic compounds of Formula (I), pharmaceutical compositions containing such a compound and their therapeutic uses, methods for their preparation, intermediate compounds, pharmaceutical compositions containing such a compound, and their therapeutic uses.